Abstract
An all-in-one polymeric nanocapsule system that combines blood-brain barrier (BBB) crossing and glioblastoma (GBM) dual-targeting peptide, intratumoral degradable disulfide cross-linker, and genome editing tool CRISPR-Cas9 is reported to show exquisite BBB penetration and brain tumor therapy with negligible off-target gene editing.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
